Articles Tagged With: treatment
-
Vitamin C, Thiamine, and Hydrocortisone for Septic Shock
The combination of vitamin C, thiamine, and hydrocortisone did not improve outcomes compared with hydrocortisone alone in patients with septic shock.
-
Pharmacotherapy Considerations for COVID-19
A summary of selected pharmacotherapy options proposed to treat COVID-19.
-
Pain Management in the Emergency Department: Opioids and Alternative Pain Management Therapies
Opioid therapy can be an effective form of pain management in the ED for acute painful conditions. The risk of addiction and abuse should be considered in every case. Alternatives to opioid therapy include systemic agents, such as acetaminophen, NSAIDs, lidocaine, alpha agonists, anticonvulsants, ketamine, corticosteroids, and local and regional anesthesia.
-
Frontline Caregivers Work Through Fear and Anxiety to Respond to COVID-19 Outbreak
Providers across the country are racing to expand capacity and stretch their supplies of personal protective equipment and life-saving ventilators.
-
Revenue Cycle at Forefront of Organizational Changes
At hospitals across the United States, administrators had to quickly create effective processes to separate COVID-19 patients from other patients. Revenue cycle leaders have been closely involved in this.
-
A Roadmap for Tobacco Cessation Treatment
In the United States, about 500,000 people die each year from tobacco-related illness. Although tobacco use has decreased in recent years, its devastation continues to plague many, especially those marginalized by social or health disparities.
-
Infectious Disease Alert Updates
Urinary Fermentation Syndrome? Residential Legionellosis From Potable Water; Which Treatment for SARS-CoV-2 Is Best?
-
Imipenem, Cilastatin, Relebactam (Recarbrio)
In July 2019, the Food and Drug Administration (FDA) approved imipenem, cilastatin, relebactam for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis and complicated intra-abdominal infections (cIAI).
-
Pharmacotherapy Considerations for COVID-19
This article provides a brief summary of selected pharmacotherapy options proposed for COVID-19.
-
Be Vigilant Distinguishing Between EVALI and Flu-Associated Pneumonia
If dealing with the COVID-19 outbreak and peak flu season are not enough, frontline providers in the ED also need to remain on the lookout for cases of e-cigarette or vaping product use-associated lung injury (EVALI). One big problem is that the symptoms of these illnesses can overlap, making it difficult to distinguish between flu-associated pneumonia and EVALI.